IP Library Granted Patent US 11,071,623
Granted Patent B2
US 11,071,623 · App. 16/346,048 · Granted Jul 27, 2021

Minimally invasive nasal implants and systems and methods

Inventors: Michael H. Rosenthal (Menlo Park, CA); Donald A. Gonzales (Austin, TX); Brian Domecus (San Francisco, CA); Scott J. Baron (Menlo Park, CA); Sergio Salinas (Redwood City, CA)
Assignee: Spirox, Inc.
A61F2/186A61B17/24A61B17/320068A61B17/320016A61B17/320725A61B2017/320056A61F2210/0004A61F2220/0016A61F2220/0033A61F2220/0075A61F2230/0013A61F2230/0054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,623
App. No.
16/346,048
Granted
Jul 27, 2021
Kind
B2
Abstract

Nasal implants and nasal implant delivery tools are described herein. The nasal implants and tools can be used to deliver the implant in a minimally invasive way. The delivery tools can be adapted to separate the upper lateral cartilage from the septum and to place an implant between the septum and the upper lateral cartilage. The implant can be configured to be placed between the upper lateral cartilage and the septum. The implant system can include a first longitudinal body adapted to engage with upper lateral cartilage and the septum on a first side of the septum and a second longitudinal body adapted to engage with upper lateral cartilage and the septum on a second side of the septum.

Claims (40)

1. A nasal implant comprising:

a first longitudinal body adapted to engage with a septum or a septal cartilage of a patient;

a second longitudinal body adapted to engage with a cartilage or an upper lateral cartilage of the patient;

a plurality of barbs along at least one of the first and second longitudinal bodies; and

a feature on at least one of the first and second longitudinal bodies adapted to connect the first and second longitudinal bodies,

wherein the nasal implant is sized to reside within a nasal tissue of the patient between a mucosa, the septum or septal cartilage, and the upper lateral cartilage to increase a cross-sectional area of a nasal airway.

2. The nasal implant of any claim 1 , further comprising a curved portion connecting the first longitudinal body and the second longitudinal body.

3. The nasal implant of claim 1 , wherein at least one of the first longitudinal body or the second longitudinal body comprises a plurality of openings adapted to receive a suture or allow tissue ingrowth.

4. The nasal implant of claim 1 , further comprising a plurality of openings on the first longitudinal body adapted to receive a plurality of features extending from the second longitudinal body.

5. The nasal implant of claim 4 , wherein the plurality of features extending from the first longitudinal body include at least one feature selected from a group consisting of: barbs, hooks, slots, grooves, or projections.

6. The nasal implant of claim 1 , wherein the first longitudinal body, the second longitudinal body, and a connection between the first longitudinal body and second longitudinal body define a U-shape or V-shape.

7. A nasal implant comprising:

a first longitudinal portion having an inner surface adapted to engage with a first side of a septum or a septal cartilage of a patient and an outer surface adapted to engage with an upper lateral cartilage of the patient;

a second longitudinal portion having an inner surface adapted to engage with a second side of the septum or the septal cartilage of the patient and an outer surface adapted to engage with the upper lateral cartilage of the patient;

a plurality of barbs along an outer surface of the first longitudinal portion and a plurality of barbs along an outer surface of the second longitudinal portion; and

a bridge portion connecting the first longitudinal portion and the second longitudinal portion adapted to engage with the septum or septal cartilage,

wherein the nasal implant is sized to reside within a nasal tissue of the patient between a mucosa, the septum or septal cartilage, and the upper lateral cartilage to increase a cross-sectional area of a nasal airway.

8. A nasal implant comprising:

a first longitudinal portion having an inner surface adapted to engage with a first side of a septum or a septal cartilage of a patient and an outer surface adapted to engage with an upper lateral cartilage of the patient;

a second longitudinal portion having an inner surface adapted to engage with a second side of the septum or the septal cartilage of the patient and an outer surface adapted to engage with the upper lateral cartilage of the patient;

a plurality of barbs along an outer surface of the first longitudinal portion and a plurality of openings along an outer surface of the second longitudinal portion adapted to engage with the plurality of barbs; and

a bridge portion connecting the first longitudinal portion and the second longitudinal portion adapted to engage with the septum or septal cartilage,

wherein the nasal implant is sized to reside within a nasal tissue of the patient between a mucosa, the septum or septal cartilage, and the upper lateral cartilage to increase a cross-sectional area of a nasal airway.

9. The nasal implant of claim 7 , wherein at least one of the first longitudinal portion or the second longitudinal portion comprises a plurality of openings adapted to receive a suture or allow tissue ingrowth.

10. The nasal implant of claim 7 , wherein the bridge portion is made out of at least one of a mesh material, textile, sheet, suture, or other open cell structure.

11. The nasal implant of claim 7 , wherein the first longitudinal portion and the second longitudinal portion define a U-shape or V-shape.

12. The nasal implant of claim 1 , wherein the first longitudinal body and the second longitudinal body are made out of a bioabsorbable material.

13. The nasal implant of claim 12 , wherein the bioabsorbable material is selected from the group consisting of: a poly(lactide); a poly(glycolide); a poly(lactide-co-glycolide); a poly(lactic acid); a poly(glycolic acid); a poly(lactic acid-co-glycolic acid);

poly(lactide)/poly(ethylene glycol) copolymers; a poly(glycolide)/poly(ethylene glycol) copolymers; a poly(lactide-co-glycolide)/poly(ethylene glycol) copolymers; a poly(lactic acid)/poly(ethylene glycol) copolymers; a poly(glycolic acid)/poly(ethylene glycol) copolymers;

a poly(lactic acid-co-glycolic acid)/poly(ethylene glycol) copolymers; a poly(caprolactone);

poly(caprolactone)/poly(ethylene glycol) copolymers a poly(orthoester); a poly(phosphazene); a poly(hydroxybutyrate) or a copolymer including a poly(hydroxybutyrate); a poly(lactide-co-caprolactone); a polycarbonate; a polyesteramide; a polyanhidride; a poly(dioxanone); a poly(alkylene alkylate); a copolymer of polyethylene glycol and a polyorthoester; a biodegradable polyurethane; a poly(amino acid); a polyetherester; a polyacetal; a polycyanoacrylate; a poly(oxyethylene)/poly(oxypropylene) copolymer, or a blend or copolymer thereof.

14. The nasal implants of claim 1 , wherein the first longitudinal body and the second longitudinal body are made out of a spun PTFE or poly-L-lactic acid (PLLA).

15. The nasal implant of claim 1 , wherein the first longitudinal body and the second longitudinal body are made out of a non-bioabsorbable material.

16. The nasal implant of claim 15 , wherein the non-bioabsorbable material is selected from the group consisting of: ethylene vinyl acetate (EVA), poly(meth)acrylic acid, polyamides, silicone-based polymers and copolymers and mixtures thereof.

17. The nasal implant of claim 7 , wherein the first longitudinal portion and the second longitudinal portion are made out of a bioabsorbable material.

18. The nasal implant of claim 7 , wherein the first longitudinal portion and the second longitudinal portion are made out of a non-bioabsorbable material.

19. The nasal implant of claim 8 , wherein the bridge portion is made out of at least one of a mesh material, textile, sheet, suture, or other open cell structure.

20. The nasal implant of claim 8 , wherein the first longitudinal portion, the second longitudinal portion, and the bridge portion define a U-shape or V-shape.

21. The nasal implant of claim 8 , wherein the first longitudinal portion and the second longitudinal portion are made out of a bioabsorbable material.

22. The nasal implant of claim 8 , wherein the first longitudinal portion and the second longitudinal portion are made out of a non-bioabsorbable material.

Assignments (3)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: SPIROX, INC.
To: STRYKER CORPORATION
Reel/Frame 068178/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2019
From: ROSENTHAL, MICHAEL H.; GONZALES, DONALD A.; DOMECUS, BRIAN; BARON, SCOTT J.; SALINAS, SERGIO
To: SPIROX, INC.
Reel/Frame 049025/0928 →